Key Market Indicators
Sales of digestive system disorder medicines in South Korea are set to reach around $4.7 billion by 2026. This is up from $4.3 billion in 2021 – a 1.6% annual growth rate on average since 2013. In 2021, South Korea was the third-largest market for these drugs, behind Japan ($4.3 billion) and Canada ($4.3 billion).